However, in CRC the FGFR3 IIIc variant was found to increase predominantly in a subgroup of advanced tumors and to exert oncogenic functions by a gain of broader ligand specificity important for tumor progression [8]. The gene discussed is FGFR3; the disease is colorectal carcinoma.